Policy | April 09, 2021
Pharma sector has both brainpower and manpower to drive growth: Mandaviya
The government has taken all the effective measures to make healthcare affordable
The government has taken all the effective measures to make healthcare affordable
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
174 applications were received for 23 eligible products under Target Segment IV - Other Chemical Synthesis Based KSMs/ Drug Intermediates/APIs.
The company received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum.
The consideration to be paid will be AUD 2.0 mn for 12.5% stake.
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
Be One is a 100% Ayurvedic health and wellness supplement.
_256_384.jpg)
Indian Chemical News, an online news media covering Pharma, Chemical and Petrochemical sector is organizing an E-conference on “India's Pharma Industry Outlook 2021” on 12th February, 2021 from 3:00 PM – 4:30 PM.
Subscribe To Our Newsletter & Stay Updated
